Loading...
PhD Irena Oblak

PhD Irena Oblak
no.: 20052 source: ARIS

researcher – active in research organisation
Foreign language skills
Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   
Keywords
Radiotherapy, oncology, head and neck cancer, Hb
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Points
239.25
A''
2.57
A'
39.84
A1/2
110.8
CI10
862
CImax
329
h10
15
A1
0.74
A3
1.48
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024 (2019, 2020, 2021, 2022, 2023)
Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 64  996  920  14.38 
Scopus 45  1,160  1,084  24.09 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (100%, RD:20%)  Institute of Oncology Ljubljana  Department of research 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. V3-2322  Framework development for evidence-based, sustainable implementation of organised population-based screening for prostate cancer in Slovenia (PETER)   10/1/2023 - 9/30/2026  PhD Irena Oblak   3,290 
2. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   10/1/2021 - 9/30/2025  PhD Gregor Serša   7,319 
3. J3-2528  Immuno gene electrotransfer of IL-12 and IL-2 in immunologically cold/hot tumors   9/1/2020 - 8/31/2023  PhD Maja Čemažar   3,424 
4. V3-2032  The impact of COVID-19 on the cancer management in Slovenia   10/1/2020 - 9/30/2022  PhD Tina Žagar   2,246 
5. J3-9269  Clinico-pharmacological approach to optimize the therapeutic bleomycin concentration in patients undergoing electrochemotherapy   7/1/2018 - 6/30/2021  PhD Gregor Serša   3,831 
6. J3-8202  Spremljanje imunskega odziva v realnem času po in situ vakcinaciji z elektrokemoterapijo in pridruženo gensko terapijo z interlevkinom-12 (Slovene)   5/1/2017 - 4/30/2020  PhD Maja Čemažar   3,811 
7. J3-7460  Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model   1/1/2016 - 12/31/2018  PhD Primož Strojan   4,561 
8. J3-6793  Novi pristopi radiosenzibilizacije tumorjev z gensko terapijo (Slovene)   7/1/2014 - 6/30/2017  PhD Gregor Serša   5,483 
9. J3-4211  Antiangiogena genska terapija raka: tarčno zdravljenje z uporabo elektroporacije in magnetnih nanodelcev kot dostavnih sistemov (Slovene)   7/1/2011 - 6/30/2014  PhD Gregor Serša   6,891 
10. J3-4259  Priprava in validacija terapevtskih plazmidov brez selekcijskega gena za antibiotično rezistenco za gensko terapijo raka z inducibilnimi in tkivno specifičnimi promotorji (Slovene)   7/1/2011 - 6/30/2014  PhD Maja Čemažar   6,296 
11. J3-6044  Nove poti zdravljenja pljučnega raka (Slovene)   7/1/2004 - 6/30/2007  PhD Matjaž Zwitter   2,888 
12. J3-4308  Napovedni pomen katepsinov in stefinov pri napredovalnem karcinomu glave in vratu zdravljenem s konkomitantno radiokemoterapijo (Slovene)   7/1/2002 - 6/30/2005  PhD Alojz Šmid   2,132 
13. J3-4176  Predklinične raziskave elektrogenske terapije v onkologiji (Slovene)   7/1/2002 - 6/30/2005  PhD Maja Čemažar   5,082 
14. J3-3021  Multimodality treatment for lung cancer   7/1/2001 - 6/30/2004  PhD Matjaž Zwitter   1,838 
ARIS research and infrastructure programmes Legend
source: ARIS
We were not given permission by the researcher to publish data.
Views history
Favourite